﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Fusion IP News RSS Feed</title>
    <link>http://www.fusionip.co.uk/News/</link>
    <description>Keep updated with Fusion IP's latest news.</description>
    <ttl>10</ttl>
    <name>
    </name>
    <user>
    </user>
    <image />
    <item>
      <title>Trade Sale of Axordia Limited to Intercytex Group plc</title>
      <pubDate>Mon, 22 Dec 2008 00:00:00 GMT</pubDate>
      <description>
		Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class university research into business, is pleased to announce today that it has divested its shareholding in Axordia Limited (“Axordia”), a stem cell company, to Intercytex Group...</description>
      <link>http://www.fusionip.co.uk/News/Axordia+Sale.htm?p=1</link>
    </item>
    <item>
      <title>Preliminary results for the year ended 31 July 2008</title>
      <pubDate>Wed, 8 Oct 2008 00:00:00 GMT</pubDate>
      <description>
		Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class research into business, is pleased to announce its Preliminary Results for the twelve months ended 31 July 2008....</description>
      <link>http://www.fusionip.co.uk/News/Preliminary+results+for+year+2008.htm?p=1</link>
    </item>
    <item>
      <title>Magnomatics raises &amp;#163;0.5m to accelerate technology development</title>
      <pubDate>Mon, 29 Sep 2008 00:00:00 GMT</pubDate>
      <description>
		Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class university research into business, is pleased to announce that Magnomatics Limited (“Magnomatics”), a spin-out company from the University of Sheffield that has invented a range of...</description>
      <link>http://www.fusionip.co.uk/News/Magnomatics+Sept+08+funding.htm?p=1</link>
    </item>
    <item>
      <title>Phase Focus completes first 'lenless' optical microscope prototype and raises &amp;#163;250k in additional funding</title>
      <pubDate>Fri, 26 Sep 2008 00:00:00 GMT</pubDate>
      <description>
		Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class university research into business, is pleased to announce that it has invested £125,000 in Phase Focus Limited (“Phase Focus”), a spin-out company from the University of...</description>
      <link>http://www.fusionip.co.uk/News/Phase+Foqus+sept+08+funding.htm?p=1</link>
    </item>
    <item>
      <title>Medaphor raises &amp;#163;250k to bring ultrasound training simulator to market</title>
      <pubDate>Mon, 15 Sep 2008 00:00:00 GMT</pubDate>
      <description>
		Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class university research into business, is pleased to announce that it has co-invested £75,000 in MedaPhor (“MedaPhor”), a spin-out company from the Cardiff University, that produces innovative...</description>
      <link>http://www.fusionip.co.uk/News/Medaphor+Sept+08+funding.htm?p=1</link>
    </item>
    <item>
      <title>Completion of Sheffield Expansion, Fundraising and Name Change to Fusion IP</title>
      <pubDate>Fri, 1 Aug 2008 00:00:00 GMT</pubDate>
      <description>
		Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class university research into business, is pleased to announce today the completion of the Group’s expanded 10 year exclusive agreement with the University of Sheffield and £2.115...</description>
      <link>http://www.fusionip.co.uk/News/Sheffield+expansion+and+name+change.htm?p=1</link>
    </item>
    <item>
      <title>Biofusion expands exclusive agreement with Sheffield to include all IP and proposes to change name to Fusion IP</title>
      <pubDate>Mon, 7 Jul 2008 00:00:00 GMT</pubDate>
      <description>
		Biofusion plc (AIM: BFN), the university IP commercialisation company that turns world class university research into business, is pleased to announce today that it has expanded its existing&amp;nbsp; 10 year exclusive agreement with the University of Sheffield to include the...</description>
      <link>http://www.fusionip.co.uk/News/Sheffield+Expansion.htm?p=1</link>
    </item>
    <item>
      <title>Biofusion present at Third Annual Piper Jaffray Europe Conference</title>
      <pubDate>Mon, 23 Jun 2008 00:00:00 GMT</pubDate>
      <description>
		
				Biofusion plc (AIM: BFN), the university IP commercialisation company that turns world class research into business, 
				announces that David Baynes, the Company’s Chief Executive Officer, will be attending the Third Annual Piper Jaffray Europe...</description>
      <link>http://www.fusionip.co.uk/News/DB+at+PJ+Conference.htm?p=1</link>
    </item>
    <item>
      <title>Board change</title>
      <pubDate>Thu, 12 Jun 2008 00:00:00 GMT</pubDate>
      <description>
		
				Biofusion plc (AIM: BFN), the university IP commercialisation company that turns world class research into business, announces today that Simon Oakland, Non-Executive Director of Biofusion, has ceased to work for NPI Ventures Limited (NPI) and as...</description>
      <link>http://www.fusionip.co.uk/News/Plc+board+change+Oakland.htm?p=1</link>
    </item>
    <item>
      <title>Pfizer report demonstrates value of Simcyp virtual studies</title>
      <pubDate>Tue, 10 Jun 2008 00:00:00 GMT</pubDate>
      <description>
		
				A new report to appear in the British Journal of Clinical Pharmacology&amp;nbsp; &amp;nbsp;shows how pharmaceutical...</description>
      <link>http://www.fusionip.co.uk/News/Simcyp+Pfizer+report.htm?p=1</link>
    </item>
  </channel>
</rss>